The Cancer Letter

Inside information on cancer research and drug development

Vol.
1
No.
9
April 05, 1974Apr 05, 1974
Free
DOWNLOAD THE PDF

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel

Rauscher Tells Flood Subcommittee How He Would Spend An Extra $50 Million-On Centers, Grants

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account